AMAG Pharmaceuticals is a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care. The company markets three key products: Makena, an injection to reduce the risk of preterm birth in singleton pregnancy; Feraheme, an IV iron replacement therapy for adult patients with chronic kidney disease and iron deficiency anemia; and MuGard, an oral wound rinse for the management of oral mucocitis/stomatiits and other types of oral wounds. The company is dedicated to addressing unmet medical needs and improving the lives of patients through innovative solutions.
AMAG Pharmaceuticals, Inc.'s ticker is AMAG
The company's shares trade on the NASDAQ stock exchange
They are based in Waltham, Massachussets
There are 201-500 employees working at AMAG Pharmaceuticals, Inc.
It is http://www.amagpharma.com/
AMAG Pharmaceuticals, Inc. is in the Healthcare sector
AMAG Pharmaceuticals, Inc. is in the Biotechnology industry
The following five companies are AMAG Pharmaceuticals, Inc.'s industry peers: